164 related articles for article (PubMed ID: 24481866)
1. Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma.
Andersson BÅ; Lewin F; Lundgren J; Nilsson M; Rutqvist LE; Löfgren S; Laytragoon-Lewin N
J Cancer Res Clin Oncol; 2014 Mar; 140(3):515-9. PubMed ID: 24481866
[TBL] [Abstract][Full Text] [Related]
2. Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck.
Lathers DM; Achille NJ; Young MR
Hum Immunol; 2003 Dec; 64(12):1160-6. PubMed ID: 14630398
[TBL] [Abstract][Full Text] [Related]
3. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells.
Young MR; Wright MA; Lozano Y; Prechel MM; Benefield J; Leonetti JP; Collins SL; Petruzzelli GJ
Int J Cancer; 1997 Feb; 74(1):69-74. PubMed ID: 9036872
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma.
Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866
[TBL] [Abstract][Full Text] [Related]
5. The use of rapid and cost-effective blood-based biomarkers in combination with tumour TNM stage for individual head and neck cancer patient treatment selection.
Laytragoon Lewin N; Lewin F; Andersson BÅ; Löfgren S; Rutqvist LE
Med Oncol; 2017 Apr; 34(4):63. PubMed ID: 28316053
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study.
Tartour E; Deneux L; Mosseri V; Jaulerry C; Brunin F; Point D; Validire P; Dubray B; Fridman WH; Rodriguez J
Cancer; 1997 Apr; 79(7):1401-8. PubMed ID: 9083163
[TBL] [Abstract][Full Text] [Related]
7. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck.
Soylu L; Ozcan C; Cetik F; Paydaş S; Kiroğlu M; Aydoğan B; Sargin O; Ozşahinoglu C; Seyrek E
Am J Otolaryngol; 1994; 15(4):281-5. PubMed ID: 7978027
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
Avilés-Jurado FX; Flores JC; Gumà J; Ceperuelo-Mallafré V; Casanova-Marqués R; Gómez D; Vendrell JJ; León X; Vilaseca I; Terra X
Head Neck; 2017 Dec; 39(12):2501-2511. PubMed ID: 28963801
[TBL] [Abstract][Full Text] [Related]
10. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.
Roslind A; Johansen JS; Christensen IJ; Kiss K; Balslev E; Nielsen DL; Bentzen J; Price PA; Andersen E
Int J Cancer; 2008 Feb; 122(4):857-63. PubMed ID: 17957792
[TBL] [Abstract][Full Text] [Related]
11. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression.
Mojtahedi Z; Khademi B; Hashemi SB; Abtahi SM; Ghasemi MA; Fattahi MJ; Ghaderi A
Pathol Oncol Res; 2011 Mar; 17(1):7-10. PubMed ID: 20340055
[TBL] [Abstract][Full Text] [Related]
12. Effect of intraoperative glucose fluctuation and postoperative IL-6, TNF-α, CRP levels on the short-term prognosis of patients with intracranial supratentorial neoplasms.
Liu TC; Liu QR; Huang Y
Asian Pac J Cancer Prev; 2014; 15(24):10879-82. PubMed ID: 25605194
[TBL] [Abstract][Full Text] [Related]
13. Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India.
Choudhury B; Srivastava S; Choudhury HH; Purkayastha A; DuttaGupta S; Ghosh SK
Tumour Biol; 2014 Jul; 35(7):6739-48. PubMed ID: 24715304
[TBL] [Abstract][Full Text] [Related]
14. Mid-pregnancy maternal plasma levels of interleukin 2, 6, and 12, tumor necrosis factor-alpha, interferon-gamma, and granulocyte-macrophage colony-stimulating factor and spontaneous preterm delivery.
Curry AE; Vogel I; Drews C; Schendel D; Skogstrand K; Flanders WD; Hougaard D; Olsen J; Thorsen P
Acta Obstet Gynecol Scand; 2007; 86(9):1103-10. PubMed ID: 17712652
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
[TBL] [Abstract][Full Text] [Related]
16. IL-1 and TNF-alpha but no IL-2 expression is found in squamous cell carcinomas of the head and neck by RT-PCR.
Knerer B; Hulla W; Martinek H; Formanek M; Temmel A; Kornfehl J
Acta Otolaryngol; 1996 Jan; 116(1):132-6. PubMed ID: 8820364
[TBL] [Abstract][Full Text] [Related]
17. Macrophage colony-stimulating factor as a tumor marker for squamous cell carcinoma of the head and neck.
Kuropkat C; Dünne AA; Plehn S; Ossendorf M; Herz U; Renz H; Werner JA
Tumour Biol; 2003; 24(5):236-40. PubMed ID: 15001836
[TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
19. Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer.
Avilés-Jurado FX; Terra X; Gómez D; Flores JC; Raventós A; Maymó-Masip E; León X; Serrano-Gonzalvo V; Vendrell J; Figuerola E; Chacón MR
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1733-41. PubMed ID: 24858806
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
